These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 27215895)
1. Comparison of allergenic extracts from different origins: the value of the FDA's bioequivalent allergy unit (BAU). Passalacqua G; Sastre J; Pfaar O; Wahn U; Demoly P Expert Rev Clin Immunol; 2016 Jul; 12(7):733-9. PubMed ID: 27215895 [TBL] [Abstract][Full Text] [Related]
2. Allergen immunotherapy (AIT) for the multiple-pollen sensitive patient. Nelson HS Expert Rev Clin Pharmacol; 2016 Nov; 9(11):1443-1451. PubMed ID: 27687128 [TBL] [Abstract][Full Text] [Related]
3. Treatment of seasonal allergic rhinoconjunctivitis with a once-daily SQ-standardized grass allergy immunotherapy tablet. Nelson H; Lehmann L; Blaiss MS Curr Med Res Opin; 2012 Jun; 28(6):1043-51. PubMed ID: 22502864 [TBL] [Abstract][Full Text] [Related]
4. Maintenance dosing for sublingual immunotherapy by prominent European allergen manufacturers expressed in bioequivalent allergy units. Larenas-Linnemann D; Esch R; Plunkett G; Brown S; Maddox D; Barnes C; Constable D Ann Allergy Asthma Immunol; 2011 Nov; 107(5):448-458.e3. PubMed ID: 22018618 [TBL] [Abstract][Full Text] [Related]
5. Sublingual-oral administration of standardized allergenic extracts: phase 1 safety and dosing results. Esch RE; Bush RK; Peden D; Lockey RF Ann Allergy Asthma Immunol; 2008 May; 100(5):475-81. PubMed ID: 18517081 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of recombinant and native timothy pollen (rPhl p 1, 2, 5, 6, 7, 11, 12 and nPhl p 4)- specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients. Rossi RE; Monasterolo G Int Arch Allergy Immunol; 2004 Sep; 135(1):44-53. PubMed ID: 15286445 [TBL] [Abstract][Full Text] [Related]
7. Allergy immunotherapy tablet: Grazax® for the treatment of grass pollen allergy. Senna GE; Calderon M; Milani M Expert Rev Clin Immunol; 2011 Jan; 7(1):21-7. PubMed ID: 21162646 [TBL] [Abstract][Full Text] [Related]
8. Allergen extracts for immunotherapy: to mix or not to mix? Nony E; Martelet A; Jain K; Moingeon P Expert Rev Clin Pharmacol; 2016; 9(3):401-8. PubMed ID: 26652799 [TBL] [Abstract][Full Text] [Related]
9. Ragweed Pollen Allergy: Burden, Characteristics, and Management of an Imported Allergen Source in Europe. Chen KW; Marusciac L; Tamas PT; Valenta R; Panaitescu C Int Arch Allergy Immunol; 2018; 176(3-4):163-180. PubMed ID: 29788026 [TBL] [Abstract][Full Text] [Related]
10. Current insights in allergen immunotherapy. Passalacqua G; Bagnasco D; Ferrando M; Heffler E; Puggioni F; Canonica GW Ann Allergy Asthma Immunol; 2018 Feb; 120(2):152-154. PubMed ID: 29413339 [TBL] [Abstract][Full Text] [Related]
11. Biological potency of German cockroach allergen extracts determined in an inner city population. Slater JE; James R; Pongracic JA; Liu AH; Sarpong S; Sampson HA; Satinover SM; Woodfolk JA; Mitchell HE; Gergen PJ; Eggleston PA Clin Exp Allergy; 2007 Jul; 37(7):1033-9. PubMed ID: 17581196 [TBL] [Abstract][Full Text] [Related]
12. Phleum pratense alone is sufficient for allergen-specific immunotherapy against allergy to Pooideae grass pollens. Hejl C; Wurtzen PA; Kleine-Tebbe J; Johansen N; Broge L; Ipsen H Clin Exp Allergy; 2009 May; 39(5):752-9. PubMed ID: 19222498 [TBL] [Abstract][Full Text] [Related]
13. An alternative allergen:adjuvant formulation potentiates the immunogenicity and reduces allergenicity of a novel subcutaneous immunotherapy product for treatment of grass-pollen allergy. Rask C; Lund L; Lund G; Heydenreich B; Wurtzen P; Bellinghausen I; Saloga J; Lund K Clin Exp Allergy; 2012 Sep; 42(9):1356-68. PubMed ID: 22925322 [TBL] [Abstract][Full Text] [Related]
14. Treatment of respiratory allergy with allergy immunotherapy tablets. Bachert C Allergy; 2011 Jul; 66 Suppl 95():57-9. PubMed ID: 21668858 [TBL] [Abstract][Full Text] [Related]
15. Quality requirements for allergen extracts and allergoids for allergen immunotherapy. Zimmer J; Bonertz A; Vieths S Allergol Immunopathol (Madr); 2017 Dec; 45 Suppl 1():4-11. PubMed ID: 29128092 [TBL] [Abstract][Full Text] [Related]
16. Oral allergy syndrome in patients with airborne pollen allergy treated with specific immunotherapy. Czarnecka-Operacz M; Jenerowicz D; Silny W Acta Dermatovenerol Croat; 2008; 16(1):19-24. PubMed ID: 18358104 [TBL] [Abstract][Full Text] [Related]
17. Understanding differences in allergen immunotherapy products and practices in North America and Europe. Mahler V; Esch RE; Kleine-Tebbe J; Lavery WJ; Plunkett G; Vieths S; Bernstein DI J Allergy Clin Immunol; 2019 Mar; 143(3):813-828. PubMed ID: 30850069 [TBL] [Abstract][Full Text] [Related]
18. European allergen extract units and potency: review of available information. Larenas-Linnemann D; Cox LS; Ann Allergy Asthma Immunol; 2008 Feb; 100(2):137-45. PubMed ID: 18320915 [TBL] [Abstract][Full Text] [Related]
19. The use of standardized extracts in allergen immunotherapy. Nelson HS J Allergy Clin Immunol; 2000 Jul; 106(1 Pt 1):41-5. PubMed ID: 10887303 [TBL] [Abstract][Full Text] [Related]
20. Dosing of European sublingual immunotherapy maintenance solutions relative to monthly recommended dosing of subcutaneous immunotherapy. Larenas-Linnemann DE; Mösges R Allergy Asthma Proc; 2016; 37(1):50-6. PubMed ID: 26831847 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]